Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Monday, November 10, 2025
Advertising
About Us
Subscribe to Newsletter
Facebook
Twitter
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Pharma
Pharma
Pharma
AstraZeneca Reports Positive Phase III NATRON Results Showing FASENRA Delayed Disease Worsening in Hypereosinophilic Syndrome
Life Sciences Times
-
November 7, 2025
Pharma
Astria Therapeutics Reports Final Positive Results from All Enrolled HAE Patients in ALPHA-STAR Phase 1b/2 Trial of Navenibart
Life Sciences Times
-
November 6, 2025
Pharma
Calluna Pharma Receives U.S. FDA Orphan Drug Designation for CAL101 in Idiopathic Pulmonary Fibrosis
Life Sciences Times
-
October 31, 2025
Pharma
Delix Therapeutics Reports Positive Phase Ib Results for Zalsupindole and FDA Clearance for Phase II Trial with At-Home Administration
Life Sciences Times
-
October 28, 2025
Pharma
Corsera Health Files First Phase 1 Clinical Trial Application for Preventive RNAi Medicine Targeting Cardiovascular Disease
Life Sciences Times
-
October 27, 2025
Pharma
Corsair Pharma Announces Successful Completion of Preclinical Program for Its Treprostinil Prodrug Transdermal System
Life Sciences Times
-
March 17, 2025
0
Pharma
Shorla Oncology Announces Expansion of U.S. Commercial Footprint with Launch of Dedicated Sales Force and Market Access Teams
Life Sciences Times
-
March 4, 2025
0
Pharma
FDA Approves Genentech’s TNKase® in Acute Ischemic Stroke in Adults
Life Sciences Times
-
March 3, 2025
0
Pharma
Selkirk Pharma Introduces ClinFAST™ to Expedite Fill/Finish for Clinical Trials
Life Sciences Times
-
February 12, 2025
0
Pharma
Fresenius Kabi Introduces Calcitonin Salmon Injection, USP Synthetic
Life Sciences Times
-
February 11, 2025
0
Pharma
Alloy Therapeutics Establishes Multi-Year Collaboration with Pfizer to Develop New Antibody Discovery Platform
Life Sciences Times
-
February 11, 2025
0
Pharma
Osta Therapeutics Strengthens Leadership Team with Two Industry Experts Supporting its Goal of Addressing Antibiotic Resistance
Life Sciences Times
-
January 30, 2025
0
Pharma
LIB Therapeutics Announces Publication of Phase 3 Study of Lerodalcibep in Homozygous Familial Hypercholesterolemia (HoFH) in Lancet Diabetes & Endocrinology
Life Sciences Times
-
January 27, 2025
0
Pharma
MAIA Biotechnology Granted FDA Rare Pediatric Disease Designation for THIO as a Treatment for Pediatric High-Grade Gliomas
Life Sciences Times
-
December 16, 2024
0
Pharma
Sudo Biosciences Announces First Participants Dosed in Phase 1 Trial of Brain-Penetrant Allosteric TYK2 Inhibitor SUDO-550
Life Sciences Times
-
December 2, 2024
0
Pharma
Precision BioSciences Highlights Preclinical Data and Outlines Design of First-in-Human Clinical Trial for PBGENE-HBV for Treatment of Chronic Hepatitis B
Life Sciences Times
-
November 15, 2024
0
Pharma
Aptar Pharma Enters into Exclusive Agreement with Cambridge Healthcare Innovations to Commercialize the Quattrii Dry Powder Inhaler Platform
Life Sciences Times
-
November 7, 2024
0
1
...
22
23
24
...
83
Page 23 of 83
Most Read
Arena BioWorks to Shut Down Amid Challenging Biotech Market Conditions
November 7, 2025
A2 Biotherapeutics Presents Initial EVEREST-2 Data, Including First Complete Response to CAR T-Cell Therapy in a Patient with NSCLC
November 7, 2025
Dechra Becomes Human-Animal Bond Certified Company to Support Veterinarians and Public Health
November 7, 2025
AstraZeneca Reports Positive Phase III NATRON Results Showing FASENRA Delayed Disease Worsening in Hypereosinophilic Syndrome
November 7, 2025